Selling cosmetics in the United States is a major business opportunity—but it comes with strict regulatory obligations. Imported cosmetic products must fully comply with laws enforced by the US FDA, just like domestically manufactured products. There are no relaxed standards for foreign manufacturers.
With the enactment of the Modernization of Cosmetics Regulation Act (MoCRA), the regulatory framework for imported cosmetics has become more structured and enforceable. Foreign companies must ensure facility registration, product listing, safety substantiation, labeling compliance, and Good Manufacturing Practices (GMP) alignment before products enter the US market.
XPRO America is a professional US FDA Consultancy supporting international cosmetic brands with complete US import compliance solutions.
Do Imported Cosmetics Need FDA Approval?
Cosmetic products generally do not require premarket approval from the US FDA before sale (except for certain color additives). However:
- Cosmetics must be safe
- Labels must be compliant
- Facilities must be registered
- Products must be listed
- Safety substantiation must be maintained
If these conditions are not met, imported cosmetics may be detained or refused entry.
Key FDA Requirements for Imported Cosmetics
Foreign cosmetic manufacturers must comply with the following:
- Facility Registration under MoCRA
- Cosmetic Product Listing
- Labeling Compliance
- Safety Substantiation
- Mandatory Cosmetic GMP
- Adverse Event Reporting
- Color Additive Compliance
Each requirement plays a critical role in import approval.
1. Cosmetic Facility Registration
Under MoCRA, facilities that manufacture or process cosmetics for the US market must register with the US FDA.
This applies to:
- Foreign manufacturers
- Contract manufacturers
- Private label production facilities
Registration must include accurate facility information. The US FDA may assign an FEI number during this process.
Failure to register may result in import refusal.
2. Cosmetic Product Listing
Each cosmetic product marketed in the United States must be listed with the US FDA.
Product listing includes:
- Product name
- Ingredient list
- Responsible Person
- Manufacturing facility information
Listing inconsistencies may delay import clearance.
3. US Labeling Requirements
Imported cosmetics must meet US labeling standards, including:
- Statement of Identity
- Net Quantity of Contents (US and metric units)
- Ingredient declaration (INCI names)
- Responsible Person name and address
- Required warning statements
Foreign labeling formats often differ from US standards and must be adjusted before shipment.
XPRO America conducts full label compliance reviews for import readiness.
4. Safety Substantiation
Under MoCRA, companies must maintain adequate safety substantiation.
For imported cosmetics, safety documentation must include:
- Ingredient safety assessments
- Toxicological review
- Exposure analysis
- Finished product testing (where applicable)
If US FDA requests records, they must be available promptly.
5. Mandatory Cosmetic GMP
Cosmetics must be manufactured under sanitary and controlled conditions.
Foreign facilities must implement:
- Written SOPs
- Quality control systems
- Batch records
- Raw material qualification
- Cleaning and sanitation procedures
If manufacturing conditions are deemed insanitary, products may be considered adulterated.
6. Serious Adverse Event Reporting
If a serious adverse event occurs in the United States, the Responsible Person must report it to the US FDA within 15 business days.
Foreign companies must establish systems to:
- Monitor complaints
- Investigate adverse events
- Maintain records
Failure to report serious events is a violation.
7. Color Additive Compliance
Color additives used in cosmetics must:
- Be approved for cosmetic use
- Be used within permitted conditions
- Be batch-certified if required
Unapproved color additives are a common reason for import detention.
Import Screening and Port Entry
Imported cosmetics are screened by US Customs and Border Protection (CBP) and may be reviewed by the US FDA.
Products may be detained if:
- Labeling is incorrect
- Ingredients are prohibited
- Facility registration is missing
- Product listing is incomplete
- Safety documentation is inadequate
Detention delays can cause financial and reputational damage.
Common Reasons Imported Cosmetics Are Refused
- Missing facility registration
- Incorrect ingredient declaration
- Drug-like claims
- Prohibited ingredients
- Microbial contamination
- Missing warnings
- No Responsible Person listed
Most issues are preventable with proper compliance review.
Responsible Person Requirement
Under MoCRA, a Responsible Person must be identified for each cosmetic product sold in the United States.
For foreign brands, this may be:
- A US distributor
- A US subsidiary
- A designated regulatory representative
The Responsible Person holds legal responsibility for compliance.
XPRO America supports foreign companies in structuring Responsible Person arrangements.
Best Practices for Import Compliance
- Register facilities before shipping
- Complete product listing
- Conduct label compliance review
- Prepare safety substantiation files
- Implement GMP systems
- Verify color additive approval
- Monitor claims
- Work with an experienced US FDA Consultancy
How XPRO America Supports Imported Cosmetic Compliance
XPRO America operates as a trusted US FDA Consultancy providing:
- Facility registration management
- Cosmetic product listing submission
- Label compliance review
- Safety substantiation preparation
- GMP implementation support
- Import readiness audits
- Regulatory strategy consulting
For professional assistance, contact support@xproamerica.com.
Compliance Perspective
The US cosmetic market offers significant opportunity, but imported cosmetics must meet the same regulatory standards as domestic products. Under US FDA authority and MoCRA enforcement, foreign companies must take proactive compliance measures to avoid detention, refusal, or enforcement action.
With expert guidance from XPRO America, international cosmetic brands can confidently enter and maintain access to the US market while meeting all US FDA regulatory requirements.
Leave a Reply